The DZIP1L gene helps kidney cells use primary cilia, tiny structures that sense signals and help control tubule growth. In medicine, this gene is important because it helps regulate how certain proteins reach these cilia. When both copies of the gene carry disease causing variants, a person can develop autosomal recessive polycystic kidney disease, which leads to cysts in the kidneys and sometimes the liver. This can cause enlarged kidneys, high blood pressure, and lower kidney function over time.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or regulate processes in the body. Some genes hold the instructions for making proteins, the working parts of cells. Others mainly help determine when, where, and how strongly certain processes take place. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, more information is available in the LearnHub.
Overview
DZIP1LGene function
What if the gene works
The DZIP1L gene helps build and organize primary cilia, tiny cell projections that act like sensors. In kidney and liver cells, this supports normal signaling and fluid handling.
Risk
What if the gene does not work
Biallelic variants in the DZIP1L gene can cause autosomal recessive polycystic kidney disease, with kidney cysts, enlarged kidneys, and reduced kidney function. Some people also develop liver cysts or scarring, and features can range from milder to more severe.
Treatment
What does that mean for your treatment
No treatment or drug choice is currently tailored specifically to pathogenic variants in the DZIP1L gene. Research is mainly focused on how the DZIP1L gene affects cilia and cyst formation, rather than on a proven targeted therapy.
Conditions associated with DZIP1L
Gene function
What if the gene works
Understanding DZIP1L gene function helps explain how many cells organize a tiny surface projection called a primary cilium, which acts like a sensing antenna. This gene mainly supports how that structure is assembled and how key proteins are guided into the right place. When it works normally, cells can carry out everyday sensing tasks in a steady, orderly way.
The DZIP1L gene helps cells build and organize the base of the primary cilium. This base works like an anchor and starting point for the cell’s tiny antenna.
Inside the cilium, the DZIP1L gene helps guide certain proteins to the right spot. This careful routing supports smooth signaling at the cilium’s entry region.
Many cells use primary cilia to detect signals from their surroundings. By supporting normal cilia structure, the DZIP1L gene helps cells respond to these everyday cues in a coordinated way.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and help shape normal human diversity, including variation in appearance, metabolism, and the way the body responds to environmental influences. Many variants do not cause any noticeable effects and are simply part of natural genetic variation. At times, though, a variant can change how a gene works more significantly and may contribute to or lead to a genetic condition.
Genetic variants
What if the gene does not work
DZIP1L gene variants can alter the protein’s shape, stability, or placement at the base of the cell’s cilium, a tiny antenna-like structure. This can disturb how key signaling proteins are positioned there and weaken cilium function. Milder missense variants may leave some protein activity, while more disruptive variants can greatly reduce or stop protein production. In DZIP1L gene variant effects, this range can influence how early cystic kidney and liver features appear and how marked they become.
How variants are linked to conditions
Pathogenic variants in the DZIP1L gene are linked to autosomal recessive polycystic kidney disease, a rare inherited condition affecting the kidneys and sometimes the liver. In this setting, DZIP1L gene variants linked to autosomal recessive polycystic kidney disease can lead to kidney cysts, enlarged kidneys, high blood pressure, and reduced kidney function over time. Liver involvement may also occur, though it is often milder than in some other forms of ARPKD.
A variant is not necessarily a diagnosis
Variants are a usual feature of human biology and are widely found across the population. Most do not directly affect health and instead reflect normal human variation. For many genes, having a variant associated with a condition suggests a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a role. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For DZIP1L, risk is mostly shaped by inheritance: people usually develop related kidney disease only if they inherit two changed copies, one from each parent. There is not enough evidence that lifestyle changes lower the chance of having a DZIP1L-related condition. Regular kidney checkups can still help find problems early and support treatment.
Inheritance of DZIP1L variants
DZIP1L-related kidney disease is inherited in an autosomal recessive pattern. This means a person usually develops the condition only when they inherit two nonworking copies of the DZIP1L gene, one from each parent. Parents who each carry one DZIP1L gene variant are typically unaffected carriers, and with each pregnancy they have a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child with neither variant. In families asking how DZIP1L variants are inherited, this also means the condition can affect boys and girls equally.
What does my DZIP1L result mean for my family?
For families with a disease-causing change in the DZIP1L gene, close relatives may also be carriers even if they have no symptoms. Brothers and sisters of an affected child may also be affected or may be carriers, and other blood relatives may want to learn whether the gene change runs in the family. This is most relevant when both parents carry a changed copy of DZIP1L.
Genetic information
Genetic testing
How you find out about variants
DZIP1L genetic testing looks for changes in the DZIP1L gene, usually from a blood sample or saliva, by reading the gene’s DNA code in a lab. Results can show whether you carry a variant linked to certain inherited cystic kidney conditions and may also help clarify carrier status in families.
When should I consider getting a genetic test?
Testing for DZIP1L may be worth considering when a baby, child, or adult has signs of inherited cystic kidney disease, such as enlarged kidneys, kidney cysts, or related liver scarring, especially if similar problems run in the family. It can help confirm the cause and clarify whether relatives may also carry the gene change.
A genetic result is only one part of your health story
A genetic finding can offer useful insight, but how much it explains depends on the condition and the type of variant involved. Over time, many factors shape how the body works, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body handles medicines, so the same treatment may work differently from one person to another. Some people break down a drug more slowly or more quickly, which can change how much of the medicine reaches the body over time. This can influence how well a treatment works or how likely someone is to notice side effects. These differences are common and are one reason medication response is often personal.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect a person’s response to medication. By looking at relationships between genes and drugs, it helps explain why treatments may work differently from one person to another. For many medicines, genes influence both how the body processes a drug and how strongly that drug acts. This information can support more informed and individualized treatment decisions. To explore this topic in greater detail, you can learn more in the LearnHub.
Drugs influenced by the DZIP1L gene
When should I seek medical advice?
There is no broadly confirmed evidence that changes in this gene meaningfully guide medication choices at this time, so questions about side effects, new symptoms, or how well a treatment is working are best discussed with your doctor.